Matthew J. Walter

Active 1994–2025

65
Papers
26,909
Citations
47
h-index
62
i10-index

Citations

Citations per year for Matthew J. Walter1995: 1 citations1996: 2 citations1997: 2 citations1998: 3 citations1999: 5 citations2000: 4 citations2001: 2 citations2002: 2 citations2003: 1 citations2004: 4 citations2005: 2 citations2006: 4 citations2007: 7 citations2008: 7 citations2009: 99 citations2010: 155 citations2011: 259 citations2012: 315 citations2013: 401 citations2014: 479 citations2015: 501 citations2016: 600 citations2017: 553 citations2018: 545 citations2019: 1,252 citations2020: 1,257 citations2021: 1,081 citations2022: 897 citations2023: 666 citations2024: 901 citations2025: 391 citations2026: 17 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,154 citing papers, 31.6% of this breakdownChina: 1,153 citing papers, 8.8% of this breakdownUnited Kingdom: 919 citing papers, 7% of this breakdownGermany: 836 citing papers, 6.3% of this breakdownItaly: 570 citing papers, 4.3% of this breakdownFrance: 510 citing papers, 3.9% of this breakdownCanada: 469 citing papers, 3.6% of this breakdownJapan: 400 citing papers, 3% of this breakdownSpain: 386 citing papers, 2.9% of this breakdownNetherlands: 377 citing papers, 2.9% of this breakdownAustralia: 304 citing papers, 2.3% of this breakdownSweden: 280 citing papers, 2.1% of this breakdown
0%31.6%Other 21.3%

Fields

  • Medicine50.2%
  • Biochemistry, Genetics and Molecular Biology43.2%
  • Immunology and Microbiology3.2%
  • Computer Science1.2%
  • Neuroscience0.6%
  • Chemistry0.4%
  • Other1.2%

Topics

  • Acute Myeloid Leukemia Research11.2%
  • Cancer Genomics and Diagnostics8.1%
  • Epigenetics and DNA Methylation5.1%
  • Myeloproliferative Neoplasms: Diagnosis and Treatment3.2%
  • RNA modifications and cancer3.2%
  • Hematopoietic Stem Cell Transplantation2.3%
  • Other66.9%

Coauthors

All papers

Open in search
  1. Mutational landscape and significance across 12 major cancer types

    Authors: , , , , , , , , , , , , , , , , , , - Nature 2013 cited by 4,556

  2. Age-related mutations associated with clonal hematopoietic expansion and malignancies

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Medicine 2014 cited by 1,887

  3. Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Nature 2014 cited by 891

  4. DNMT3A Mutations in Acute Myeloid Leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gary W. Swift, Jerry P. Reed, Patricia A. Alldredge, Todd Wylie, Jason Walker, Joelle Kalicki, Mark A. Watson, Sharon E. Heath, William D. Shannon, Nobish Varghese, Rakesh Nagarajan, Peter Westervelt, Michael H. Tomasson, Daniel C. Link, Timothy A. Graubert, John F. DiPersio, Elaine R. Mardis, Richard K. Wilson - New England Journal of Medicine 2010 cited by 1,980

  5. Immune Escape of Relapsed AML Cells after Allogeneic Transplantation

    Authors: , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2018 cited by 471

  6. Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Attilio Orazi, Elli Papaemmanuil, Andreas Reiter, David M. Ross, Michael R. Savona, Akiko Shimamura, Radek C. Skoda, Françesc Solé, Richard M. Stone, Ayalew Tefferi, Matthew J. Walter, David Wu, Benjamin L. Ebert, Mario Cazzola - Blood 2022 cited by 208

  7. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , William D. Shannon, Jacqueline E. Payton, Shashikant Kulkarni, Peter Westervelt, Matthew J. Walter, Timothy A. Graubert, Elaine R. Mardis, Richard K. Wilson, John F. DiPersio - Nature 2012 cited by 2,027

  8. Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rick Meyer, Jonathan K. Schindler, Craig Pohl, John W. Wallis, Xiaoqi Shi, Ling Lin, Heather K. Schmidt, Yuzhu Tang, Carrie A. Haipek, Madeline E. Wiechert, Jolynda V. Ivy, Joelle Kalicki, Glendoria Elliott, Rhonda E. Ries, Jacqueline E. Payton, Peter Westervelt, Michael H. Tomasson, Mark A. Watson, Jack Baty, Sharon E. Heath, William D. Shannon, Rakesh Nagarajan, Daniel C. Link, Matthew J. Walter, Timothy A. Graubert, John F. DiPersio, Richard K. Wilson, Timothy J. Ley - New England Journal of Medicine 2009 cited by 2,226

  9. The Origin and Evolution of Mutations in Acute Myeloid Leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jasreet Hundal, Lisa L. Cook, Gary W. Swift, Jerry P. Reed, Patricia A. Alldredge, Todd Wylie, Jason Walker, Mark A. Watson, Sharon E. Heath, William D. Shannon, Nobish Varghese, Rakesh Nagarajan, Jacqueline E. Payton, Jack Baty, Shashikant Kulkarni, Jeffery M. Klco, Michael H. Tomasson, Peter Westervelt, Matthew J. Walter, Timothy A. Graubert, John F. DiPersio, Li Ding, Elaine R. Mardis, Richard K. Wilson - Cell 2012 cited by 1,576

  10. TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Madina Sukhanova, Randall W. Knoebel, Wendy Stock, Timothy A. Graubert, Matthew J. Walter, Peter Westervelt, Daniel C. Link, John F. DiPersio, Timothy J. Ley - New England Journal of Medicine 2016 cited by 784

  11. SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Detlef Haase, Heinz Tüchler, Peter L. Greenberg, Seishi Ogawa, Eva Hellström‐Lindberg, Mario Cazzola - Blood 2020 cited by 293

  12. Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid Cancers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2021 cited by 298

  13. Clonal Hematopoiesis and Risk of Incident Lung Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 cited by 83

  14. U2AF1 mutations induce oncogenic IRAK4 isoforms and activate innate immune pathways in myeloid malignancies

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Cell Biology 2019 cited by 252

  15. Proteomic and phosphoproteomic landscapes of acute myeloid leukemia

    Authors: , , , , , , , , , , , , , , , , , , - Blood 2022 cited by 124

  16. SciClone: Inferring Clonal Architecture and Tracking the Spatial and Temporal Patterns of Tumor Evolution

    Authors: , , , , , , , , , , , , , , , , - PLoS Computational Biology, PLoS Comput. Biol. 2014 cited by 495

  17. Systematic Analysis of Splice-Site-Creating Mutations in Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jean C. Zenklusen, Jiashan Zhang, Sudha Chudamani, Jia Liu, Laxmi Lolla, Rashi Naresh, Todd Pihl, Qiang Sun, Yunhu Wan, Ye Wu, Juok Cho, Timothy Defreitas, Scott Frazer, Nils Gehlenborg, Gad Getz, David I. Heiman, Jaegil Kim, Michael S. Lawrence, Pei Lin, Sam Meier, Michael S. Noble, Gordon Saksena, Doug Voet, Hailei Zhang, Brady Bernard, Nyasha Chambwe, Varsha Dhankani, Theo Knijnenburg, Roger Kramer, Kalle Leinonen, Yuexin Liu, Michael I. Miller, Sheila M. Reynolds, Ilya Shmulevich, Vésteinn Thórsson, Wei Zhang, Rehan Akbani, Bradley M. Broom, Apurva M. Hegde, Zhenlin Ju, Rupa S. Kanchi, Anil Korkut, Jun Li, Han Liang, Shiyun Ling, Wenbin Liu, Yiling Lu, Gordon B. Mills, Kwok-Shing Ng, Arvind Rao, Michaël Ryan, Jing Wang, John N. Weinstein, Jiexin Zhang, Adam Abeshouse, Joshua Armenia, Debyani Chakravarty, Walid K. Chatila, Ino de Bruijn, Galen F. Gao, Benjamin Groß, Zachary Heins, Ritika Kundra, Konnor La, Marc Ladanyi, Augustin Luna, Moriah G. Nissan, Angelica Ochoa, Sarah Phillips, Ed Reznik and 651 more - Cell Reports 2018 cited by 250

  18. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David Gordon, Asif Chinwalla, Yu Zhao, Rhonda E. Ries, Jacqueline E. Payton, Peter Westervelt, Michael H. Tomasson, Mark A. Watson, Jack Baty, Jennifer Ivanovich, Sharon E. Heath, William D. Shannon, Rakesh Nagarajan, Matthew J. Walter, Daniel C. Link, Timothy A. Graubert, John F. DiPersio, Richard K. Wilson - Nature 2008 cited by 1,440

  19. TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michaëla Fontenay, Olivier Kosmider, Michal Bar‐Natan, David P. Steensma, Richard M. Stone, Michael Heuser, Felicitas Thol, Mario Cazzola, Luca Malcovati, Aly Karsan, Christina Ganster, Eva Hellström‐Lindberg, Jacqueline Boultwood, Andrea Pellagatti, Valeria Santini, Lynn Quek, Paresh Vyas, Heinz Tüchler, Peter L. Greenberg, Rafael Bejar - Leukemia 2019 cited by 259

  20. Bam-readcount - rapid generation of basepair-resolution sequence metrics

    Authors: , , , , , , , , , , , , - The Journal of Open Source Software, J. Open Source Softw. 2022 cited by 141

  21. Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Genetics 2011 cited by 582

  22. Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potential

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2018 cited by 198

  23. Spliceosome Mutations Induce R Loop-Associated Sensitivity to ATR Inhibition in Myelodysplastic Syndromes

    Authors: , , , , , , , - Cancer Research 2018 cited by 164

  24. CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML Progression

    Authors: , , , , , , , , , , , , , , , , , , - Cell 2017 cited by 225